[1]
Akumu, E.O. 2026. Balancing Favourable Drug-Likeness Against Respiratory and Renal Liabilities: An Integrated In Silico ADME–Toxicity Profile of a Novel 3-{[2-(Formimidoylamino)ethyl]sulfanyl}-6-(1-methoxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carbonyl fluoride. Editon Consortium Journal of Research in Medical and Health Sciences. 6, 1 (Sep. 2026), 28–40. DOI:https://doi.org/10.51317/ecjrmhs.v6i1.758.